88216665 - RECON BIOINFORMATICS ENGINE

Information

• Trademark
• 88216665

• Source

• Serial Number

  88216665

• Registration Number

  5866191

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 04, 2018
  6 years ago

• Registration Date

  September 24, 2019
  5 years ago

• Transaction Date

  September 24, 2024
  4 months ago

• Status Date

  September 24, 2019
  5 years ago

• Published for Opposition Date

  July 09, 2019
  5 years ago

• Location Date

  June 03, 2022
  2 years ago

• First Use Anywhere Date

  March 02, 2018
  6 years ago

• First Use In Commerce Date

  March 02, 2018
  6 years ago

• Status Code

  700

• Current Location

  TMO LAW OFFICE 116

  Employee Name

  BENMAMAN, ALICE

• Attorney Docket Number

  3814.0340001

  Attorney Name

  Monica Riva Talley

  Law Office Assigned Location Code

  M70

• Owners

  • Neon Therapeutics, Inc.

Case File Statements

• DM0000: The mark consists of the word "RECON" with a double helix design incorporated in the letter E stacked on top of the words "BIOINFORMATICS" and "ENGINE" in the lower right corner.
• A00001: Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
• CC0000: Color is not claimed as a feature of the mark.
• GS0441: Medical and pharmaceutical consultation; providing information relating to therapeutic properties of pharmaceuticals
• DS0000: "BIOINFORMATICS ENGINE"
• GS0421: Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; and consulting services for others in the field of design, planning, and implementation of clinical trials

Case File Event Statements

• 3/4/2019 - 5 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/7/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 12/21/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/22/2018 - 6 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/5/2019 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/5/2019 - 5 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/5/2019 - 5 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/16/2019 - 5 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/16/2019 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/17/2019 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/18/2019 - 5 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/3/2019 - 5 years ago

  12 - ASSIGNED TO LIE Type: ALIE

• 6/19/2019 - 5 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/9/2019 - 5 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/9/2019 - 5 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/24/2019 - 5 years ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/6/2022 - 3 years ago

  17 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 6/3/2022 - 2 years ago

  18 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 6/3/2022 - 2 years ago

  19 - NEW CERTIFICATE UNDER SECTION 7 - PROCESSED Type: C.7C

• 9/24/2024 - 4 months ago

  20 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1